Cangrelor Pregnancy and Breastfeeding Warnings
Brand names: Kengreal
Cangrelor Pregnancy Warnings
Safety has not been established during pregnancy.
US FDA pregnancy category: C
Animal studies have revealed evidence of fetal growth retardation and increased incidences of abortion and intrauterine losses. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Cangrelor Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Product Information. Kengreal (cangrelor). The Medicines Company. 2015.
References for breastfeeding information
- Product Information. Kengreal (cangrelor). The Medicines Company. 2015.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
